Carbon Biosciences

Edit info

Founded: 2021

Location: Lexington, MA

Employee range: 11 - 50

Clinical stage: RD

Therapy area: Cystic fibrosis

Drug types: LNG, GEN

Lead product: CGT-001

Funding: $38M A Jun 2022

Investors: Agent Capital, Longwood Fund, Solasta Ventures, Astellas, Camford Capital, UTokyoIPC

carbonbio.com

linkedin.com

job board

About:

Carbon Biosciences is using their proprietary CBN vector library to advance gene therapy by increasing tissue specificity and allowing for larger payloads. They are developing genetic medicines utilizing next-generation viral vectors for the treatment of the most devastating and difficult-to-treat diseases. Dr. Robert Kotin, a leader in adeno-associated vector research, and John F. Engelhardt are the scientific founders of Carbon Biosciences in 2021.

Jobs:

Main

Contact: recruit@workinbiotech.com